TY - JOUR
T1 - Emerging perspectives on lipid management
T2 - International approaches and global challenges
AU - Gotto, Antonio M.
N1 - Funding Information:
The meeting, Modern Lipid Management: New Approaches for the New Millenium , was held on June 28, 2000, in Stockholm, Sweden. The meeting was chaired by Yuichiro Goto, MD, PhD, Emeritus Professor, Tokai University, Emeritus Director, Kugayama Hospital, Kanagawa, Japan; and Antonio M. Gotto, Jr., MD, DPhil, Dean and Professor of Medicine, Weill Medical College of Cornell University, New York, New York. The participants were Jean Davignon, OC, MD, Professor of Medicine, Professor of Nutrition, University of Montreal, Director, Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Group of Montreal, Montreal, Quebec, Canada; Scott M. Grundy, MD, PhD, Director, Center for Human Nutrition, Chairman, Department of Clinical Nutrition, Distinguished Professor of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School, Chief of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts; Hiroshi Mabuchi, MD, Professor of Internal Medicine, Kanazawa University School of Medicine, Kanazawa, Japan; Yuji Matsuzawa, MD, Professor of Internal Medicine, Osaka University School of Medicine, Osaka, Japan; Thomas A. Pearson, MD, MPH, PhD, Albert D. Kaiser Professor, Chairman, Department of Community and Preventive Medicine, Professor of Medicine, University of Rochester School of Medicine, Rochester, New York; Terje R. Pedersen, MD, PhD, Professor of Clinical Cardiology, Aker University Hospital, University of Oslo, Oslo, Norway; Yasushi Saito, MD, Professor, Second Department of Internal Medicine, Chiba University, Chiba, Japan; Tamio Teramoto, MD, Professor of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. The meeting was sponsored by Pfizer Japan and Yamanouchi Pharmaceutical Company, Tokyo, Japan.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2001/10/15
Y1 - 2001/10/15
N2 - The rapid growth in the understanding of the relation between cholesterol and coronary heart disease has introduced new challenges to the contemporary management of lipid disorders. The publication of the trials of the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitors (statins) has invigorated support for the lipid hypothesis, and many advances have been made in understanding the mechanisms underlying atherosclerosis and the potential benefits of the statins. Several international groups have issued guidelines about desirable and undesirable lipid values to help clinical decision making. Despite the availability of such principles, there are many challenges to optimal management of lipid disorders.
AB - The rapid growth in the understanding of the relation between cholesterol and coronary heart disease has introduced new challenges to the contemporary management of lipid disorders. The publication of the trials of the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitors (statins) has invigorated support for the lipid hypothesis, and many advances have been made in understanding the mechanisms underlying atherosclerosis and the potential benefits of the statins. Several international groups have issued guidelines about desirable and undesirable lipid values to help clinical decision making. Despite the availability of such principles, there are many challenges to optimal management of lipid disorders.
UR - http://www.scopus.com/inward/record.url?scp=0035887168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035887168&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(01)01895-1
DO - 10.1016/S0002-9149(01)01895-1
M3 - Comment/debate
C2 - 11676951
AN - SCOPUS:0035887168
VL - 88
SP - 876
EP - 881
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 8
ER -